APLS
Apellis Pharmaceuticals Inc
Price:
17.82
USD
Volume:
1,810,589
United States | Biotechnology
Apellis EV/EBITDA
-266.4 %
Upside
As of 2025-07-03, the EV/EBITDA ratio of Apellis Pharmaceuticals Inc (APLS) is -12.53. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Apellis's latest enterprise value is 2,335 mil USD. Apellis's TTM EBITDA according to its financial statements is -186 mil USD. Dividing these 2 quantities gives us the above Apellis EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing EV/EBITDA multiples | 11.9x - 13.8x | 13.7x |
| Forward EV/EBITDA multiples | 18.9x - 34.6x | 30.9x |
| Fair Price | (28.71) - (21.27) | (29.65) |
| Upside | -261.1% - -219.3% | -266.4% |
17.82 USD
Stock Price
(29.65) USD
Fair Price
| (USD in millions except Fair Price) | |||
| Trailing | Forward | ||
| Market Cap (USD mil) | EV/EBITDA | EV/EBITDA | |
| Apellis Pharmaceuticals Inc | 2,240 | N/A | N/A |
| Abbvie Inc | 336,941 | 13.7x | 49.4x |
| Amgen Inc | 159,619 | 14.4x | 20.6x |
| FibroGen Inc | 21 | 5.6x | 5.6x |
| Amicus Therapeutics Inc | 1,832 | 39.2x | 79.3x |
| Gilead Sciences Inc | 138,711 | 8.2x | 60.3x |
| Arcus Biosciences Inc | 910 | 30.9x | 30.9x |
| Regeneron Pharmaceuticals Inc | 59,139 | 12.8x | 11.9x |
| Industry median | 13.7x | 30.9x | |
| (*) EBITDA | -186 | -186 | |
| Enterprise value | (2,552) | (5,755) | |
| (-) Net debt | 95 | 95 | |
| Equity value | -2,647 | -5,850 | |
| (/) Outstanding shares | 126 | 126 | |
| Fair price | -21 | -47 | |
| July 01, 2025 | -12.57 |
| June 30, 2025 | -12.19 |
| June 27, 2025 | -12.27 |
| June 26, 2025 | -12.93 |
| June 25, 2025 | -12.92 |
| June 24, 2025 | -13.07 |
| June 23, 2025 | -12.4 |
| June 20, 2025 | -12.45 |
| June 18, 2025 | -12.49 |
| June 17, 2025 | -12.49 |
| June 16, 2025 | -12.86 |
| June 13, 2025 | -13.22 |
| June 12, 2025 | -13.51 |
| June 11, 2025 | -13.51 |
| June 10, 2025 | -13.72 |
| June 09, 2025 | -13.59 |
| June 06, 2025 | -13.52 |
| June 05, 2025 | -13.4 |
| June 04, 2025 | -13 |
| June 03, 2025 | -13.21 |
| June 02, 2025 | -13.43 |
| May 30, 2025 | -11.93 |
| May 29, 2025 | -12.26 |
| May 28, 2025 | -11.85 |
| May 27, 2025 | -11.91 |
| May 23, 2025 | -12.28 |
| May 22, 2025 | -12.51 |
| May 21, 2025 | -12.26 |
| May 20, 2025 | -13 |
| May 19, 2025 | -12.43 |
| May 16, 2025 | -12.29 |
| May 15, 2025 | -11.55 |
| May 14, 2025 | -11.78 |
| May 13, 2025 | -12.17 |
| May 12, 2025 | -12.33 |
| May 09, 2025 | -12.18 |
| May 08, 2025 | -12.53 |
| May 07, 2025 | -12.65 |
| May 06, 2025 | -13.41 |
| May 05, 2025 | -13.99 |
| May 02, 2025 | -14.24 |
| May 01, 2025 | -14.06 |
| April 30, 2025 | -13.47 |
| April 29, 2025 | -12.8 |
| April 28, 2025 | -12.63 |
| April 25, 2025 | -12.31 |
| April 24, 2025 | -12.35 |
| April 23, 2025 | -12.31 |
| April 22, 2025 | -12.23 |
| April 21, 2025 | -12.68 |